Skip links
Companies
› United States › RECURSION PHARMACEUTICALS, INC.
Company registry profile
RECURSION PHARMACEUTICALS, INC. logo

RECURSION PHARMACEUTICALS, INC.

Active

From the registry

Registration details

Registration No.
5426554
Incorporation Date
2013-04-11
Company Type
Not disclosed
Address
United States
Website
www.recursion.com/
Status
Active
Country
United States
Source: Delaware Division of CorporationsRegistry coverage
Registry summary

Company overview

RECURSION PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 5426554, and its current status with Delaware Division of Corporations is active. The company was incorporated on 11 April 2013 and lists its registered address as United States. 2 shareholders are on record for RECURSION PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including Delaware Division of Corporations.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Vanguard Group Inc 15.1% Delaware Division of Corporations

Registry notes and limitations

Two shareholders are currently on record for RECURSION PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 15.1% — the largest recorded stake — followed by BAILLIE GIFFORD & CO at 7.6%.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

5

CC
Christopher C. Gibson Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Co-founder, Ceo & Director

BC
Blake C. Borgeson Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Co-founder & Director

TM
Tina Marriott Larson ACTIVE

Residence
🇺🇸 United States
Occupation
Coo & President

KL
Kevin Leggat ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Finance & Accounting

MS
Michael Secora Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Financial Officer

Registry notes and limitations

The Co-founder, Ceo & Director of RECURSION PHARMACEUTICALS, INC. currently on record is Christopher C. Gibson Ph.d.; five officers are currently on record for RECURSION PHARMACEUTICALS, INC., filed with Delaware Division of Corporations.

The register reports 20 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at RECURSION PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Top of recorded group
RECURSION PHARMACEUTICALS, INC.
United States
Exscientia, Inc.
United StatesUS FL 7119490

Cyclica Inc
United States#0167248936

Vium, Inc.
United States#0115723700

EXSCIENTIA LIMITED+ subsidiaries
United KingdomGB 13483814

RECURSION LONDON LTD
United KingdomGB 12648333

Recursion Canada Inc
Canada#0354404933

Cerexis, Inc.
United StatesUS NY 7750351

How these relationships were recorded

RECURSION PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 7 subsidiaries recorded beneath it across 3 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 7 subsidiaries span United States, United Kingdom, Canada jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 7 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Registry questions

Frequently asked questions

Who owns RECURSION PHARMACEUTICALS, INC.?

Two shareholders are currently on record for RECURSION PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 15.1% — the largest recorded stake — followed by BAILLIE GIFFORD & CO at 7.6%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is RECURSION PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for RECURSION PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does RECURSION PHARMACEUTICALS, INC. have on record?

2 shareholders are shown on record for RECURSION PHARMACEUTICALS, INC..

What is RECURSION PHARMACEUTICALS, INC.'s company registration number?

RECURSION PHARMACEUTICALS, INC.'s registration number is 5426554, filed with Delaware Division of Corporations in United States. Its current status on the register is active.

Is RECURSION PHARMACEUTICALS, INC. still an active company?

RECURSION PHARMACEUTICALS, INC.'s status on Delaware Division of Corporations is listed as active.

When was RECURSION PHARMACEUTICALS, INC. incorporated?

RECURSION PHARMACEUTICALS, INC. was incorporated on 11 April 2013, according to Delaware Division of Corporations.

What is RECURSION PHARMACEUTICALS, INC.'s registered address?

The registered address on file for RECURSION PHARMACEUTICALS, INC. is United States.

Who are the officers/directors of RECURSION PHARMACEUTICALS, INC.?

The Co-founder, Ceo & Director of RECURSION PHARMACEUTICALS, INC. currently on record is Christopher C. Gibson Ph.d.; five officers are currently on record for RECURSION PHARMACEUTICALS, INC., filed with Delaware Division of Corporations. Management authority at RECURSION PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does RECURSION PHARMACEUTICALS, INC. have a parent company or subsidiaries?

RECURSION PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 7 subsidiaries recorded beneath it across 3 jurisdictions. Those 7 subsidiaries span United States, United Kingdom, Canada jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 7 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

This website uses cookies to improve your web experience.